Purple Biotech to Present IM1240 Data at EORTC-NCI-AACR Symposium

Bitget2026/10/29 13:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Purple Biotech will present IM1240 data at the 38th EORTC-NCI-AACR Symposium in Barcelona, Spain, Nov. 18-20, 2026.
Mount Sinai’s Amir Horowitz will deliver the plenary presentation on Nov. 20 at 15:00 CET.
The presentation will cover treatment-resistant human tumor models, IM1240’s mechanism of action, and safety evaluations of the CAPTN-3 platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Purple Biotech Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290900PRIMZONEFULLFEED9856062) on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03